BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2286201)

  • 1. Inhibition of the hepatocyte uptake of radiolabelled monoclonal antibodies by chelating agents.
    Davidson BR; Boulos PB; Porter JB
    Eur J Nucl Med; 1990; 17(6-8):294-8. PubMed ID: 2286201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
    Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C
    Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effects of diethylene triamine penta-acetic acid on the distribution of indium-111 monoclonal antibody metabolism.
    Kimura Y; Fujii T; Ochi K; Akamune A; Hamamoto K
    Eur J Nucl Med; 1992; 19(9):759-64. PubMed ID: 1396870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential application of DTPA for improving the image quality in radioimmunoscintigraphy with 111In labeled monoclonal antibodies].
    Ochi K; Fujii T; Kimura Y; Akamune A; Hamamoto K
    Kaku Igaku; 1992 Jan; 29(1):69-75. PubMed ID: 1578822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci.
    Claessens RA; Koenders EB; Boerman OC; Oyen WJ; Borm GF; van der Meer JW; Corstens FH
    Eur J Nucl Med; 1995 Mar; 22(3):212-9. PubMed ID: 7789393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
    Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
    J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of indium-111 in the liver of mice following administration of indium-111-DTPA-labeled monoclonal antibodies: influence of labeling parameters, physiologic parameters, and antibody dose.
    Schuhmacher J; Klivényi G; Matys R; Kirchgebner H; Hauser H; Maier-Borst W; Matzku S
    J Nucl Med; 1990 Jun; 31(6):1084-93. PubMed ID: 2348237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative imaging of colorectal cancers. Targeting the epithelial membrane antigen with a radiation-labeled monoclonal antibody.
    Davidson BR; Young H; Waddington WA; Babich J; Clarke GA; Short MD; Boulos PB; Styles J; Dean C; Ell PJ
    Cancer; 1992 Feb; 69(3):620-5. PubMed ID: 1730114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
    Béhé M; Becker W; Gotthardt M; Angerstein C; Behr TM
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.
    Turner A; King DJ; Farnsworth AP; Rhind SK; Pedley RB; Boden J; Boden R; Millican TA; Millar K; Boyce B
    Br J Cancer; 1994 Jul; 70(1):35-41. PubMed ID: 8018538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of a DTPA chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice.
    Sharkey RM; Motta-Hennessy C; Gansow OA; Brechbiel MW; Fand I; Griffiths GL; Jones AL; Goldenberg DM
    Int J Cancer; 1990 Jul; 46(1):79-85. PubMed ID: 2114375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody.
    Goldenberg A; Masui H; Divgi C; Kamrath H; Pentlow K; Mendelsohn J
    J Natl Cancer Inst; 1989 Nov; 81(21):1616-25. PubMed ID: 2795690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and metabolism of 111In-labeled monoclonal antibody B6.2 by the rat liver.
    Jones PL; Brown BA; Sands H
    Cancer Res; 1990 Feb; 50(3 Suppl):852s-856s. PubMed ID: 2297733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes.
    Duncan JR; Stephenson MT; Wu HP; Anderson CJ
    Cancer Res; 1997 Feb; 57(4):659-71. PubMed ID: 9044843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
    Breeman WA; Hofland LJ; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Visser TJ; Lamberts SW
    Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
    Khawli LA; Alauddin MM; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2003 Dec; 18(6):931-40. PubMed ID: 14969605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative localization of colorectal cancers using radiolabelled monoclonal antibodies.
    Davidson BR; Waddington WA; Short MD; Boulos PB
    Br J Surg; 1991 Jun; 78(6):664-70. PubMed ID: 2070229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chelating derivative of alpha-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma.
    Bard DR; Knight CG; Page-Thomas DP
    Br J Cancer; 1990 Dec; 62(6):919-22. PubMed ID: 2257220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.